Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampicin versus ursodeoxycholic acid for severe early-onset intrahepatic cholestasis of pregnancy
ACTRN12618000332224Phase 4Recruiting
- Sponsor
- University of Adelaide
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 4
01
Overview
Phase 4, randomised, open-label trial in intrahepatic cholestasis of pregnancy (ICP) comparing Rifampicin with Ursodeoxycholic acid (2 arms). Primary endpoint: Change in pruritus score. Started Oct 2019; status: recruiting.
02
Drugs
rifampicinursodeoxycholic acid
03
Conditions
intrahepatic cholestasis of pregnancy (ICP)
Beyond the preview
Go deeper on ACTRN12618000332224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000332224.